2019
Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder
DeVito EE, Carroll KM, Babuscio T, Nich C, Sofuoglu M. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. Journal Of Substance Use And Addiction Treatment 2019, 107: 29-37. PMID: 31757262, PMCID: PMC6918721, DOI: 10.1016/j.jsat.2019.08.009.Peer-Reviewed Original ResearchConceptsCocaine use disorderSignificant treatment group differencesUse disordersEfficacy of galantamineTreatment-seeking cocaine usersCurrent cocaine use disordersGroup differencesCocaine use outcomesSample of individualsTreatment group differencesComorbid opioid use disorderMethadone-maintained individualsMemory capacityAbstinent individualsCocaine useCognitive improvementCognitive outcomesCocaine use reductionCognitive functionUse outcomesCocaine usersGalantamine groupIndividualsDisordersInitial promise
2014
Cannabis Abstinence During Treatment and One-Year Follow-Up: Relationship to Neural Activity in Men
Kober H, DeVito EE, DeLeone CM, Carroll KM, Potenza MN. Cannabis Abstinence During Treatment and One-Year Follow-Up: Relationship to Neural Activity in Men. Neuropsychopharmacology 2014, 39: 2288-2298. PMID: 24705568, PMCID: PMC4138744, DOI: 10.1038/npp.2014.82.Peer-Reviewed Original ResearchConceptsCannabis-dependent groupHealthy comparison groupNeural activityCognitive controlLess cannabisDorsal anterior cingulate cortexCognitive control taskCognitive behavioral therapyTreatment development effortsCannabis-dependent individualsAnterior cingulate cortexAddiction-related processesFMRI taskSubstance use disordersCannabis abstinenceCingulate cortexVentral striatumCannabis dependenceCannabis useContingency managementLess abstinenceAbstinenceHealthy individualsCannabisGreater activity